KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cme (CME) Free Cash Flow (2016 - 2025)

Historic Free Cash Flow for Cme (CME) over the last 17 years, with Q3 2025 value amounting to $949.7 million.

  • Cme's Free Cash Flow fell 241.47% to $949.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.1 billion, marking a year-over-year increase of 1255.68%. This contributed to the annual value of $3.6 billion for FY2024, which is 648.72% up from last year.
  • Latest data reveals that Cme reported Free Cash Flow of $949.7 million as of Q3 2025, which was down 241.47% from $1.0 billion recorded in Q2 2025.
  • Cme's Free Cash Flow's 5-year high stood at $1.1 billion during Q1 2025, with a 5-year trough of $460.1 million in Q2 2021.
  • In the last 5 years, Cme's Free Cash Flow had a median value of $836.8 million in 2023 and averaged $805.7 million.
  • The largest annual percentage gain for Cme's Free Cash Flow in the last 5 years was 12801.22% (2021), contrasted with its biggest fall of 5158.88% (2021).
  • Cme's Free Cash Flow (Quarter) stood at $641.0 million in 2021, then soared by 49.31% to $957.1 million in 2022, then grew by 6.94% to $1.0 billion in 2023, then decreased by 3.11% to $991.7 million in 2024, then dropped by 4.24% to $949.7 million in 2025.
  • Its Free Cash Flow was $949.7 million in Q3 2025, compared to $1.0 billion in Q2 2025 and $1.1 billion in Q1 2025.